METTL1 and hepatocellular carcinoma: In HCC, upregulation of METTL1 and WDR4 is associated with advanced tumor stage, vascular invasion status, and poor patient survival (Wang H. et al., 2023; Wang H. et al., 2024; Wang W. et al., 2024).